Study Suggests Additional Trials May Be Warranted On the Chemopreventative and Adjuvant Therapeutic Applications of Pomegranate in Human Breast Cancer
In a recent scientific research study, pomegranates were processed into three components: fermented juice, aqueous pericarp extract and seed oil. Additional processing of these components yielded polyphenol-rich fractions. These fractions were then assessed in vitro (test tube) for possible chemopreventative or adjuvant therapeutic potential in human breast cancer cells. From the results of this assessment, researchers say it is clear that both aqueous and oily fractions of pomegranate fruits exert multiple in vitro suppressive effects on human breast cancer cells and that further trials may be warranted. Source: Breast Cancer Research and Treatment, Volume 21, 2002 Read More.
In a recent scientific research study, pomegranates were processed into three components: fermented juice, aqueous pericarp extract and seed oil. Additional processing of these components yielded polyphenol-rich fractions. These fractions were then assessed in vitro (test tube) for possible chemopreventative or adjuvant therapeutic potential in human breast cancer cells. From the results of this assessment, researchers say it is clear that both aqueous and oily fractions of pomegranate fruits exert multiple in vitro suppressive effects on human breast cancer cells and that further trials may be warranted. Source: Breast Cancer Research and Treatment, Volume 21, 2002 Read More.